Endothelial Arf6 sustains capillary electrical signaling and cerebral blood flow through PIP <sub>2</sub> regeneration and activation of Kir2.1 channels
Brain capillaries sense neural activity and direct blood flow to active regions-a process termed neurovascular coupling that underlies activity-dependent increases in local perfusion (functional hyperemia). A key contributor to functional hyperemic responses is the capillary endothelial cell (cEC) inward rectifier K<sup>+</sup> (Kir2.1) channel, which is activated by neuronal activity-derived extracellular K<sup>+</sup> and initiates vasodilatory electrical signals that propagate through the vascular network. Kir2.1 channel function requires continual production of its lipid cofactor, phosphatidylinositol-4,5-bisphosphate (PIP<sub>2</sub>), and is compromised in mouse models of cerebral small vessel (cSVD). Although decreased PIP<sub>2</sub> availability is a common feature of cSVD, mechanisms underlying PIP<sub>2</sub> synthesis remain poorly understood. We hypothesized that Arf6, a small GTPase expressed in cECs that stimulates PIP<sub>2</sub> production, is critical for this process. Using patch-clamp electrophysiology, we demonstrate that inhibiting Arf6 activity progressively decreased cEC Kir2.1 channel activity. This deficit corresponded to loss of capillary-to-arteriole electrical signaling in isolated vessels and diminished functional hyperemia <i>in vivo</i>. Exogenously provided PIP<sub>2</sub> restored Kir2.1 currents and functional hyperemia after Arf6 inhibition or genetic knockdown. Collectively, our data indicate that cEC Arf6 sustains Kir2.1 activity by maintaining PIP<sub>2</sub> levels and demonstrate that diminished PIP<sub>2</sub> synthesis is sufficient to impair functional hyperemia. Furthermore, we identify Arf6 as a mechanistic link between PIP<sub>2</sub> production and endothelial electrical signaling, highlighting Arf6 as a potential therapeutic target for restoring functional hyperemia.
Authors
- Maurizio Mandalà (ORCID: https://orcid.org/0000-0003-3736-0205)
- Masayo Koide (ORCID: https://orcid.org/0000-0002-1381-7074)
- Michael T. Yarboro (ORCID: https://orcid.org/0000-0003-1915-1979)
- María Sancho (ORCID: https://orcid.org/0000-0003-4750-1040)
- Saúl Huerta de la Cruz (ORCID: https://orcid.org/0000-0002-5968-9506)
- Mark T. Nelson (ORCID: https://orcid.org/0000-0002-6608-8784)
- M Dichgans
- Katalin Völgyi (ORCID: https://orcid.org/0009-0007-8073-9524)
- Nathalie Beaufort (ORCID: https://orcid.org/0000-0002-7088-4206)
- Maria Noterman-Soulinthavong
- Emma Moreland
- David Hill-Eubanks
Institutions
- University of Vermont (US)
- Universidad Complutense de Madrid (ES)
- German Center for Neurodegenerative Diseases (DE)
- University of Manchester (GB)
- LMU Klinikum (DE)
- Munich Cluster for Systems Neurology (DE)
- German Centre for Cardiovascular Research (DE)
- University of Calabria (IT)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2025-12-25
- DOI
- https://doi.org/10.64898/2025.12.23.696233
- Primary Topic
- Barrier Structure and Function Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Heart Association
- University of Vermont
- Deutsche Forschungsgemeinschaft
- Fondation Leducq
- Ministerio de Ciencia e Innovación
- Stiftung zur Erforschung der Vaskulären Demenz
- National Institute of General Medical Sciences